EuroAPI develops, manufactures and supplies the active-ingredient solutions for healthcare.
EuroAPI has raised $825.5M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in October 2024.
EuroAPI's investors include Sanofi.
EuroAPI is headquartered in Paris, France.
EuroAPI develops, manufactures and supplies the active-ingredient solutions for healthcare.
EuroAPI is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EuroAPI — Funding & Investors." VCBacked, October 10, 2024, https://www.vcbacked.co/company/euroapi. Accessed July 20, 2026.
VCBacked. (2024). EuroAPI — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/euroapi
{{cite web |title=EuroAPI — Funding & Investors |url=https://www.vcbacked.co/company/euroapi |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated